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The cell wall of mycobacteria is characterized by glycolipids composed of different classes of 
mycolic acids (MAs) (alpha-, keto- and methoxy-) and sugars (trehalose, glucose and 
arabinose). Studies using mutant Mtb strains have shown that the structure of MAs influences 
the inflammatory potential of these glycolipids. As mutant Mtb strains possess a complex 
mixture of glycolipids, we analyzed the inflammatory potential of single classes of mycolate 
esters of Mtb cell wall using 38 different synthetic analogues. Our results show that synthetic 
trehalose dimycolates (TDMs) and trehalose-, glucose- and arabinose-monomycolates 
(TMMs, GMMs and AraMMs) activate BMDCs in terms of production of pro-inflammatory 
cytokines (IL-6 and TNF-α) and ROS, upregulation of costimulatory molecules and activation 
of NLRP3 inflammasome by a mechanism dependent on Mincle. These findings demonstrate 
that Mincle receptor can also recognize pentose esters and seem to contradict the hypothesis 
that production of GMM is an escape mechanism used by pathogenic mycobacteria to avoid 
recognition by the innate immune system. Finally, our experiments indicate that TMM and 
GMM as well as TDM can promote Th1 and Th17 responses in mice in an OVA 
immunization model and that further analysis of their potential as novel adjuvants for subunit 







Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB) belongs to the 
single genus Mycobacterium of the Mycobacteriaceae family. Bacteria from this family are 
characterized by the presence in their cell wall of high molecular weight C-60 to C-90 2-
alkyl-3-hydroxy fatty acids called mycolic acids (MA). Mycolic acids are the major lipids 
constituting the mycobacterial cell wall [1,2], present as free mycolic acids [3] or esterified to 
different sugars. They are predominantly bound to the cell wall with arabinogalactan as penta- 
arabinose tetramycolates, but they are also present as non-bound solvent extractable esters, 
such as trehalose mono- and dimycolate (TMM and TDM), glucose monomycolate (GMM) 
and glycerol monomycolate (Gro-MM) [1,2].  
 
Among these components, trehalose 6,6’-dimycolate (TDM) - also known as cord factor – is 
the major and most studied mycolate ester. Indeed, in mouse models TDM can mimic certain 
aspects related to Mtb infection, including the production of pro-inflammatory cytokines [4,5], 
the induction of granuloma and pro-coagulant activity [6–8]. In addition, TDM can delay 
phagolysosome fusion [9], is involved in tissue damage and necrosis, and possesses adjuvant 
properties [10]. However, natural TDM used so far in these different studies was isolated 
from mycobacteria and consisted of a complex mixture of structurally related compounds 
composed of mycolates from different classes. Indeed, based on the functional group(s) 
present on their meromycolate chain, mycolic acids are subdivided in different classes. The 
principal classes are the alpha-, keto- and methoxy- mycolic acids. These classes differ 
considerably between mycobacterial species and strains [11], and appear to influence their 
virulence. For example, the attenuated vaccine strain M. bovis BCG-Pasteur lacks methoxy-
mycolic acids [12] and saprophytic mycobacteria such as M. smegmatis fail to produce 
oxygenated (keto- and methoxy-) mycolic acids [2]. In contrast, highly pathogenic 
mycobacteria such as Mtb and M. leprae produce oxygenated mycolic acids. Genetic 
inactivation of enzymatic pathways involved in the synthesis of oxygenated mycolic acids 
resulted in in vivo attenuated Mtb strains [13,14]. Therefore, the use of synthetic analogues 
can be useful to discriminate the contribution of different types of TDM or of mycolate esters 
in general to the pathogenicity of mycobacterial infection and to the inflammatory potential of 
these cell wall components. Indeed, the contribution of other mycolate esters found in the cell 
wall of Mtb such as TMM, GMM and arabinose mycolates in the activation of innate immune 
cells following mycobacterial infection is poorly defined. 
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TMM is known as a key precursor for the biosynthesis of TDM and has been reported to have 
some similarity with TDM in terms of inflammatory potential [4,15,16]. GMM has been 
demonstrated to be an antigen that is presented by CD1b molecules to T cells [17], but the 
activation of innate immune cells by GMM from Mtb is controversial. Indeed, it was reported 
that Mincle (macrophage inducible C-type lectin receptor)  does not recognise GMM obtained 
by trehalase treatment of TDM [18], but that GMM of corynebacteria (C-32 mycolates in 
corynebacteria versus C-60 to C-90 mycolates in mycobacteria) does bind to Mincle and 
activates cells [19]. Mincle and MCL (macrophage C-type lectin) have been shown to be 
essential receptors for recognition of TDM [18,20] and TMM [21] and hence crucial for 
stimulation of cord factor induced innate immune responses. On the other hand, arabino-
mycolate ester (a complex mixture of mono-arabinose monomycolates, tetra-arabinose tetra-
mycolates, penta-arabinose tetra-mycolates and hexa-arabinose tetra-mycolates) obtained by 
acid hydrolysis of BCG cell wall skeleton (CWS) was reported to induce production of TNF-
α by mechanisms dependent on TLR-2 / MyD88 pathway [22]. Finally, it has been shown that 
trehalose dibehenate (TDB), a short-acyl-chain structural analogue of TDM, activates the 
intracellular multiprotein complex called NLRP3 inflammasome [23] and that this activation 
is essential for the Th17 responses induced by TDB [24]. For the moment, it is still unknown 
whether TMM, GMM and arabinose mycolates can activate the inflammasome as well.  
 
To address the relationship between the structure and the inflammatory power of mycolate 
esters and the signalling pathways involved, we have assayed in this study thirty-eight single 
synthetic mycolate ester isomers of high purity and known stereochemistry [25–28]. The 
mycolate esters tested here vary in terms of their carbohydrate moiety (trehalose, glucose or 
arabinose) and in terms of the number, nature and class of mycolic acids bound to it. The 
selected mycolate esters are composed of mycolic acids that are representative of the major 
classes found in the cell wall of Mtb, namely alpha-, methoxy- and keto- mycolates of either 
cis or trans configuration and with different chain lengths. In addition, also synthetic 
mycolate esters composed of alpha-mycolates containing an alkene group and homologous to 
those found in non-pathogenic mycobacteria (such as M. smegmatis) have been tested here for 
comparison purposes.  Using murine bone marrow derived dendritic cells, we examined in 
vitro the ability of these compounds to induce production of pro-inflammatory cytokines 
(TNF-α, IL-6, IL-12 and IL-1β) and we identified the pathways involved in their 
inflammatory potential. We also confirmed their in vivo inflammatory potential and tested 
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Material and Methods 
Mice 
C57BL/6 wt/wt, MyD88-/- and MALT1-/- mice were bred and kept at the experimental animal 
facilities of WIV-ISP (Ukkel site, Brussels), complying with the Belgian legislation that 
transposes European Directive 2009/41/EC, repealing Directive 90/219/EC (EC, 2009). For 
some experiments, female C57BL/6 mice aged 6-8 weeks were purchased from Janvier-labs. 
Breeding pairs of MyD88-/- mice were kindly provided by C. Desmet (Cellular and Molecular 
Physiology, GIGA-Research, ULg, Belgium). MALT1-/- mice were described [29]. Bones 
(femurs and tibia) of Mincle-/-, FcRγ-/- and NLRP3-/- mice were provided by R. Lang 
(University Clinics Erlangen, Germany) and B. Ryffel (CNRS, Orleans, France). 
 
Preparation of glycolipid coated plates 
Stocks of synthetic glycolipids (synthetized at Bangor University [25–28,30,31], TDB 
(Invivogen) and natural TDM from Mtb (Adipogen) were solubilised in chloroform-methanol 
solution (9:1) at 5mg/mL. The different glycolipids were then dissolved in isopropanol and 
coated on flat bottomed culture plates (Greiner). After evaporation of the solvent, the plates 
were used directly or stored at -20°C. Final concentrations are indicated in the figure legends 
and results section. For the experiments performed at equimolar concentration, molarity of 
natural TDM (a mix) was calculated using an estimated molecular weight of 2754 g mol-1. A 
possible negative effect of the tested glycolipids on cell viability was tested by Alamar blue 
assay and no increased mortality was observed under the test conditions. 
 
Generation of BMDCs  
BMDCs were generated as previously described [32]. Briefly, murine bone marrow from 
femur and tibia was flushed with PBS and red blood cells were lysed with Sigma’s lysing 
buffer. After lysis, cells were cultured (5% CO2 at 37°C) in T75 flask in RPMI-1640 medium 
(Life Technologies, Carlsbad, CA, USA) supplemented with 10 ng/mL recombinant murine 
GM-CSF (Immunotools), 5 × 10−5 M 2-mercaptoethanol, 100 µg/mL gentamycin (GIBCO), 
2mM glutamine, 1 mM sodium pyruvate, non-essential amino acids (Thermo Fisher 
Scientific) and 10% fetal calf serum (FCS, Greiner). Cells were differentiated for 6-7 days 
and the medium was replaced every 3 days. 90 % of CD11c positive cells were obtained after 
differentiation.  
 
In vitro stimulation with glycolipids and analysis of samples 
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BMDCs were harvested after 7 days using a cell scraper, counted and seeded in glycolipid-
coated plates at a concentration of 106 cells/ mL for different time periods. Culture 
supernatants were collected after 24h and the content of pro-inflammatory cytokines TNF-α, 
IL-12p40, IL-1β and IL-6 was determined by ELISA (eBiosciences).  
Expression of co-stimulatory molecules was analysed after 48h of incubation with the 
different compounds. Cells were labelled with anti-mouse CD80, anti-mouse CD86 and anti-
mouse MHC class II monoclonal antibodies (eBiosciences). Fluorescence was analysed using 
a FACSCalibur flow cytometer and analysed with CELL-QUEST software (BD Biosciences). 
  
HEK-blue mMincle stimulation 
Human embryonic kidney (HEK)-blue mMincle cells (Invivogen) stably transfected with 
murine C-type lectin receptor mincle gene, as well as the genes of Mincle-NF-κB signalling 
pathway and secreted alkaline phosphatase (SEAP) under the control of NF-κB activation, 
were used to analyse the activation of Mincle receptor by the compounds. HEK-blue mMincle 
cells were cultured in Dulbecco’s modified Eagle medium (DMEM) containing 4.5g/L 
glucose and supplemented with 10% FCS, selective antibiotics and 2mM glutamine. Cells 
were passed in T75 flask when 70-80% confluence was reached. For the stimulation, cells 
were seeded in 96 well plates at the density of 5.104 cells/ well for 24 h. Quanti-blue substrate 




BMDCs at 1.106 cells/ mL were primed for 3 h with 1µg/mL of E. coli K12 ultra-pure LPS 
(Invivogen) prior to stimulation with glycolipids (on coated plates) and controls. Cells were 
stimulated in triplicate with 5mM ATP (for 1h) or 10 µg/mL of mycolic acid esters (for 5h). 
For the inhibition studies, Glibenclamide (50 µM - Sigma), Ebselen (10 µM - Sigma), 
Cytochalasin D (1 µM - Sigma), CA-074 methyl ester (10 µM - Sigma) and Z-VAD-FMK (10 
µM - Invivogen) were added 1h prior to glycolipid stimulation. The effect of these inhibitors 
on cell viability was tested by Alamar blue or MTT assay and no increased mortality was 
observed under the test conditions. IL-1β cytokine production in cell-free supernatant was 
evaluated by ELISA (eBiosciences). 
For the detection of activated caspase-1 in supernatants, cells were stimulated in FCS-free 
medium. Triplicate samples were pooled and the proteins were concentrated by methanol-
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chloroform precipitation. Briefly, 500 µl of supernatant was mixed with 500 µl of methanol 
and 125 µl of chloroform, vortexed and centrifuged. The aqueous phase was collected, 
washed with methanol, mixed and centrifuged. The supernatant was discarded and the pellet 
was dried, reconstituted in SDS sample buffer (75mM Tris-HCl, pH 6.8, 100mM DTT, 2% 
SDS, 0.01% bromophenol blue and 10 % glycerol) and heated for 5 min at 95°C. Proteins 
were separated by electrophoresis for 1h30 at 100 V in 15% Tris-Glycine Gel and transferred 
to a nitrocellulose membrane using a semi-dry system (Amersham bioscience). 3% BSA and 
TBS-Tween 20 were used respectively as blocking and washing buffer. Monoclonal mouse 
anti-caspase-1 p20 Casper-1 (Adipogen) was used as primary antibody and polyclonal goat 
anti-mouse IgG HRP (R&D systems) as a secondary antibody. The revelation was done by 
applying ECL substrate (GE Healthcare Life Sciences) on the membrane and pictures were 
taken using an ImageQuant LAS 4000 device.  
 
ROS assay 
Reactive oxygen species (ROS) were analysed with cell-permeant 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) assay according to the manufacturer’s 
protocol (Thermo Fisher Scientific). Briefly, BMDCs (106 cells/mL) were pre-incubated for 
30 minutes in PBS to allow the dye to enter the cells, washed and seeded in 24-well coated 
plates for 4 hours. ROS levels were analysed by flow cytometry. Results were analysed using 
a FACSCalibur flow cytometer and analysed with CELL-QUEST software (BD Biosciences). 
 
Footpad immunisation with Ovalbumin 
Water in oil in water emulsions (w/o/w) were prepared by minor modification of a previously 
described protocol [33]. Briefly, glycolipids were dissolved in 30% of Incomplete Freund’s 
Adjuvant (IFA) and vortexed vigorously. Next,  PBS 0.1M was added and vortexed again 
vigorously to make a water in oil emulsion and finally PBS containing 0.2 % of Tween 80 
containing the needed amount of ovalbumin was added to the water in oil preparation to make 
a water in oil in water emulsion. Groups of 4-5 mice were injected subcutaneously in both 
hind footpads with 25 µl of the emulsion containing 30% IFA, 5µg of glycolipids and 25µg of 
ovalbumin (Invivogen). Footpad swelling in individual mice was measured with a caliper 
before and at several time points after injection. 
 
Analysis of local footpad inflammation 
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One week after administration of the w/o/w samples, the mice were sacrificed and the tissues 
of the hind footpads were collected and digested using collagenase and DNAse (Sigma). Cells 
were collected and strained with a 100 -µm nylon cell strainer (BD). Total RNA was isolated 
from footpad cells with Tri-reagent (Sigma-Aldrich) according to the manufacturer’s 
instructions. cDNA was prepared using the GoScript  Reverse Transcriptase system 
(Promega). qRT-PCR was performed on Stratagene 3000p using GoTaq qPCR Master mix 
(Promega) according to the manufacturer’s instructions. Forward and reverse primers used are 
described below. GAPDH was used as reference housekeeping gene for the normalization.  
Additionally, footpad cells were incubated with Ly6G-Ly6C PE and viability dye V450 
(eBiosciences) and the fluorescence was analysed with a FACSverse device. 
Primers 
CXCL1 forward: 5’-CCGAAGTCATAGCCACACTCAA-3’ 
CXCL1 reverse: 5’-GCAGTCTGTCTTCTTTCTCCGTTAC-3’ 
IL-1β forward: 5’-TTGACGGACCCCAAAAGAT-3’ 
IL-1β reverse: 5’-AGCTGGATGCTCTCATCAGG-3’ 
IL-12p35 forward: 5’-CCTCGGCATCCAGC-3 
IL-12p35 reverse: 5’-TCTGGCCGTCCTCA-3’ 
TNF-α forward: 5’-CATCTTCTCAAAATTCGAGTGACAA-3’ 
TNF-α reverse: 5’-TGGGAGTAGACAAGGTACAACCC-3’ 
GAPDH forward: 5'-TCGGCCTTGACTGTGCCGTT-3' 
GAPDH reverse: 5'-TCCCAGCCTCGTCCCGTAGAC-3' 
  
Analysis of adaptive immune responses 
One week after subcutaneous administration of the different w/o/w preparations, mice were 
sacrificed and popliteal and inguinal lymph nodes were removed and passed through a 100 -
µm nylon cell strainer (BD). Cells were counted and stimulated in RPMI medium 
supplemented with 5 × 10−5 M 2-mercaptoethanol, antibiotics and 10% FCS in  round-bottom 
96 well plates with 5µg/mL of ovalbumin, culture medium as a negative control and 
Concanavalin A (Sigma) (4µg/mL) as a positive control. Cell free culture supernatants were 
harvested after 24h and 72h of incubation at 37°C-5% CO2. Levels of IL-2 were measured in 
24h supernatants by ELISA (eBiosciences). Levels of IFN-γ and IL-17A were determined in 
72h supernatants by ELISA (respectively BD Pharmingen and eBiosciences).  
 
Statistical analyses 
Statistical analyses were performed using Graphpad Prism 6 software (Graphpad Software, La 
Jolla, CA, USA). For the statistical analysis of the in vitro experiments, data from three to 
four independent experiments were pooled and tested for Gaussian distribution with 
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D’Agostino Pearson test followed by pairwise comparisons performed by Mann-Whitney test. 
For the analysis of the in vivo experiments, pairwise comparisons were performed by Mann-





1. Synthetic trehalose di- and mono-mycolates are inflammatory 
To study the influence of the class of mycolates and the number of mycolate chains on the 
inflammatory potential of trehalose mycolate esters, 17 trehalose dimycolates and 13 
trehalose monomycolates were synthetized (Table1, TDM and TMM columns) [25–28,30,31]. 
These compounds vary in terms of their MA class (alpha-, methoxy-, keto-), the configuration 
of their cyclopropanation (cis- versus trans-) and the number of MAs bound to trehalose 
(dimycolates versus monomycolates). Bone marrow derived dendritic cells (BMDCs) were 
incubated for 24h with the different synthetic TMMs, TDMs, evaporated isopropanol (ISO) as 
a negative control, trehalose-6,6-dibehenate (TDB) or TDM isolated from Mtb (TDM natural 
mix) as positive controls. The production of pro-inflammatory cytokines IL-6 and TNF-α was 
evaluated by ELISA in culture supernatants and results obtained for 10 TDMs and 9 TMMs at 
equimolar concentrations are shown in Figure 1, while results obtained at 10µg/ml for 16 
TDMs and 11 TMMs are shown in supplementary Table S1. All the tested synthetic TMMs 
and TDMs stimulated the production of TNF-α and IL-6. Interestingly, when dose-response 
analysis was performed with pairs of TMM and TDM composed of the same mycolate moiety, 
we observed that the number of mycolate chains bound to trehalose influenced the level of 
TNF-α and IL-6 produced. Indeed, as shown in Figure 1A and 1B, at equimolar 
concentrations the cis-methoxy TMM KB51 (monomycolate) induced TNF-α and IL-6 levels 
that were 2-3 fold lower than those achieved by stimulation with the corresponding cis-
methoxy TDM KB52 (dimycolate). TNF-α levels induced by KB51 were comparable to those 
induced by trehalose 6,6 dibehenate (TDB), while IL-6 levels induced by KB51 were lower 
than those obtained by TDB.  This influence of the number of mycolate chains on the 
intensity of the inflammatory response was observed for a total of 9 TMM / TDM pairs 
representative of the different classes and configurations of mycolates present in 
mycobacteria (Fig. 1C). Indeed, statistically significant differences in levels of TNF-α (Fig. 
1C) and IL-6 (data not shown) were observed when comparing the data obtained for a given 
TDM with the data obtained for the corresponding TMM (same mycolate moiety). In addition, 
the majority of the tested TDM compounds induced significantly more TNF-α compared to 
TDB (statistical analysis not shown). Only the dialkene TDM (ST198) and the cis-keto TDM 
(AD132) induced TNF-α levels comparable to those induced by TDB (Fig. 1C).  Concerning 
the influence of the class of MAs on the levels of inflammatory responses induced by TDM, 8 
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synthetic TDMs representative of the different classes and configurations of mycolates 
present in mycobacteria were selected and a dose response analysis was performed. All the 
tested synthetic compounds induced significant TNF-α production already at the lowest 0.001 
µM concentration tested and a plateau of response was observed at 0.1 to 1 µM 
(Supplementary Fig.S1). To compare responses induced with TDMs from the same class but 
of different configuration (cis- versus trans-), data obtained in 3 independent experiments at 
1µM with alpha-, keto- or methoxy-TDMs of cis- or trans-configuration were pooled and 
differences analyzed statistically (Fig. 1D). . Results indicated that the tested trans-alpha-
TDM (MMS139) was more inflammatory than the tested cis-alpha-TDM (MH175), while for 
the oxygenated mycolates cis- compounds were more inflammatory than trans- compounds 
(Fig. 1D). When results obtained for cis- compounds are statistically compared, cis-methoxy-
compound (KB52) induces higher TNF-α levels as compared to cis-alpha TDM (MH175) or 
cis-keto TDM (AD132). 
2. Synthetic arabinose and glucose mono-mycolates are inflammatory 
We next assessed the importance of the sugar moiety on the inflammatory potential of 
synthetic glycolipids. For that purpose, levels of pro-inflammatory cytokines produced by a 
cis-methoxy mycolate bound to trehalose (TDM-KB52 or TMM-KB51), or to glucose 
(GMM-SMP73) or arabinose (AraMM-MOD16) were evaluated. As shown in Figure 2A-D, 
significant TNF-α, IL-6, IL-12p40 and IL-1β levels were measured in BMDC culture 
supernatants with all the tested compounds after 24h of incubation. At the highest 
concentration tested (1 µM), TDB induced significantly more IL-6, IL-1β, TNF-α and IL-
12p40 than cis-methoxy AraMM-MOD16 and TMM-KB51, whereas GMM-SMP73 - 
compared to TDB - induced comparable levels of IL-1β and TNF-α but less IL-12p40 and IL-
6. Finally, TDM-KB52 induced similar levels of IL-6, IL-1β and IL-12p40 but higher TNF-α 
levels as compared to levels achieved by TDB. Overall, these data indicate that AraMM-
MOD16 is the weakest inducer of pro-inflammatory cytokines in comparison to TDM-KB52, 
TMM-KB51 and GMM-SMP73. In an additional experiment, we also compared the 
inflammatory potential of 5 synthetic GMMs and 3 AraMMs composed of mycolates from 
different classes and configuration (supplementary fig. S2). Notably, all the tested GMMs 
induced TNF-α levels at least comparable to those obtained with TDB (Fig.S2). In contrast, 
the TNF-α  levels induced with the three different synthetic AraMMs were lower than those 
induced with TDB or the tested GMMs. Thus AraMMs are the weakest inducers of pro-
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inflammatory cytokines and TDMs the strongest inducers, while TMMs and GMMs induce 
responses comparable in magnitude to those observed after stimulation with TDB.   
As a second read-out for the activation of BMDCs, we measured surface expression of co-
stimulatory molecules CD86 and CD80, major histocompatibility complex class II molecules 
(MHC-II) and production of reactive oxygen species (ROS) induced by incubation with the 
synthetic glycolipids. Expression of CD86, CD80 and MHC-II was increased after 48h of 
incubation with TDM-KB52, TMM-KB51, GMM-SMP73, AraMM-MOD16 and LPS and 
TDB controls as compared to non-stimulated BMDCs (Fig 2E). AraMM-MOD16 (and LPS) 
stimulated CD86 expression to a lesser extent that the other mycolate esters. Expression of 
CD80 and MHC class II was increased by all four compounds to the same level as by TDB. 
TDM-KB52, TMM-KB51, and GMM-SMP73 all significantly induced the production of 
intracellular ROS, while the weakest response was again observed for the synthetic AraMM 
tested (Fig. 2F). 
3. Synthetic arabinose and glucose mono-mycolates activate BMDCs by 
mechanisms dependent on C-type lectin receptor Mincle 
Several receptors have been reported to interact with mycolate esters. For example, 
recognition of natural arabinose mycolate esters has been described to be dependent on 
MyD88 and TLR-2 [22], while C-type lectin receptor Mincle and MCL receptor have been 
associated with recognition of cord factor, its structural analogue TDB, TMM and GMM from 
corynebacteria [18–21,34]. In order to identify the signaling pathways involved in the 
inflammatory responses observed with the synthetic compounds, BMDCs were generated 
from C57BL/6 WT, Myd88-/-, Mincle-/-, FcRgamma-/- and MALT1-/- mice. MALT1 and FcR 
gamma are two proteins involved in Mincle-NF-κB activation pathway. As shown in Fig. 3A, 
TNF-α production induced by LPS was dependent on Myd88 but was independent of Myd88 
for the synthetic TDM-KB52, TMM-KB51, GMM-SMP73, TDB and natural TDM mix, and 
also for AraMM-MOD16, in contrast to what was reported for natural AraMM isolated from 
BCG [22]. TNF-α production induced by LPS was, as expected, independent of Mincle, 
FcRgamma and MALT1, while complete inhibition of TNF-α production was observed in 
BMDCs from  Mincle-/-, FcRgamma-/- and MALT1-/- mice after stimulation with synthetic 
TDM-KB52, TMM-KB51, GMM-SMP73, TDB, natural TDM mix and with AraMM-
MOD16 (Fig. 3B, 3C). Similar results were obtained when piceatannol was used as an 
inhibitor of spleen tyrosine kinase, a protein involved in NF-κB activation by Mincle (data not 
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shown). In addition, we confirmed that synthetic glucose and arabinose monomycolates are 
Mincle agonists, using HEK-Blue murine Mincle reporter cell line (Invivogen) (Fig. 3D). 
Comparable levels of NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) 
were induced by TDM-KB52, TMM-KB51, GMM-SMP73 and TDB at concentrations as low 
as 0.001 µM, while one-hundred fold higher concentrations of AraMM-MOD16 were needed 
to stimulate comparable SEAP levels, suggesting a weaker interaction with Mincle. Similar 
results were obtained with all the tested synthetic TDMs, TMMs, GMMs and AraMMs 
(Fig.S3 for the TDMs’ results).  
In summary, these results indicate that synthetic GMMs and AraMMs activate BMDCs by 
mechanisms that are independent of the Myd88 pathway but dependent on Mincle-FcRγ-Syk 
MALT1 pathway, demonstrating that the C-type lectin Mincle receptor can also recognize 
mycolic acids from mycobacteria bound to glucose and arabinose.  
4. Glucose and arabinose mono-mycolates activate the NLRP3 inflammasome 
It was previously shown that the production of IL-1β induced by natural TDM (mix) and TDB 
is associated with activation of the NLRP3 inflammasome [23]. The inflammasome is a 
multiprotein platform which mediates the maturation of caspase-1. Mature caspase-1 cleaves 
pro- IL-1β and pro-IL-18 and induces the secretion of mature IL-1β and IL-18 [35]. The 
activation of the inflammasome by TDB is dependent on Mincle and has been shown to be 
essential for its ability to induce IL-17 responses [24]. As we found that synthetic GMMs and 
AraMMs also bind to Mincle and induce the production of ROS species, we next analysed 
whether these compounds could also activate the inflammasome. A selected series of 4 
mycolate esters composed of the same cis-methoxy mycolate were tested, i.e. TDM-KB52, 
TMM-KB51, GMM-SMP73 and AraMM-MOD16. BMDCs were primed with LPS 3h prior 
to incubation for 5h with the tested compounds and controls. As shown in Figure 4A, 
synthetic cis-methoxy TDM-KB52, TMM-KB51, GMM-SMP73 and AraMM-MOD16 all 
stimulated IL-1β secretion by LPS-primed BMDCs to levels comparable to those achieved by 
natural TDM and TDB. Because the secretion of IL-1β is dependent on the maturation of 
caspase-1, we also analysed the secretion of the active caspase-1 p20 subunit in the 
supernatant and we found that stimulation of LPS-primed BMDCs by TDM-KB52, TMM-
KB51, GMM-SMP73 or AraMM-MOD16 was sufficient to induce caspase-1 maturation (Fig. 
4B and 4C). Blocking of caspase activity with the pan-caspase-inhibitor z-VAD-FMK 
strongly reduced the secretion of IL-1-β (Figure 4D), while, as expected, levels of secreted 
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TNF-α were only marginally reduced following z-VAD-FMK addition (Fig.4E). Overall, 
these results indicate that also synthetic TMM, GMM and AraMM can induce in BMDCs a 
caspase-1/inflammasome dependent secretion of IL-1β. Using BMDCs derived from NLRP3-
/- KO and caspase1/11-/- mice, we observed that IL-1β induction by the tested compounds was 
completely abrogated in the absence of NLRP3 and significantly reduced in the absence of 
caspase1/11-/- (Fig.4F), demonstrating that synthetic TMM, GMM and AraMM induce 
production of IL-1β by NLRP3 dependent mechanisms (Fig. 4F). The fact that only levels of 
IL-1β but not of TNF-α were affected by the genetic deletion of NLRP3 or caspase1/11 
confirms that these deletions only impact inflammasome activation (Fig.4G). As ROS 
production, potassium efflux and cathepsin B activity are involved in inflammasome 
activation by TDB [23], we analysed whether similar mechanisms are also involved in 
BMDCs activation by synthetic mycolate esters. To this end, production of IL-1β following 
incubation of BMDCs with ROS scavenger (Ebselen) and synthetic TDM-KB52, TMM-
KB51, GMM-SMP73 and AraMM-MOD16 was measured. A significant reduction in IL-1β 
secretion was observed (Supplementary Figure S4A) following incubation with the different 
compounds in the presence of Ebselen. The inhibition of IL-1β secretion was also observed 
when Glibenclamide was used as an inhibitor of potassium efflux pump or when a culture 
medium rich in potassium was used to inhibit potassium efflux (Fig. S4B). Finally, blocking 
cathepsin B activity with pharmacological inhibitor CA-074 and blocking actin 
polymerization with cytochalasin D significantly reduced the production of IL-1β by TDB 
and synthetic TDM-KB52, TMM-KB51, GMM-SMP73 and AraMM-MOD16 mycolate esters 
without affecting the level of IL-1β induced with the positive control ATP (Fig. S4C and 
S4D). In summary, these data indicate that ROS production, potassium efflux, cathepsin B 
activity and phagocytosis are mechanisms involved in IL-1β induction by synthetic mycolate 
esters.  
5. Synthetic mycolate esters demonstrate inflammatory and adjuvant properties 
in vivo  
Our in vitro results indicated that synthetic trehalose di- and monomycolates, glucose 
monomycolates and to a lesser extent arabinose mono-mycolates had an inflammatory 
potential. To confirm these findings in vivo and to explore their possible use as novel 
adjuvants for sub-unit vaccines, water in oil in water emulsions (w/o/w) composed of 
incomplete Freund’s adjuvant (IFA) as a vehicle, synthetic mycolate esters and ovalbumin as 
a test antigen were prepared and injected once in the two hind footpads of C57BL/6 mice. 
17  
Footpad swelling was monitored for 1 week as a read-out of local inflammation; at day seven 
we analysed the type of cells recruited in the footpad and the upregulation of pro-
inflammatory chemokines and cytokines in these cells. Finally, OVA-specific immune 
responses were analysed by stimulating cells isolated from the lymph nodes draining the 
injection site 1 week after injection. Results obtained after injection of w/o/w emulsions 
composed of 30% IFA and cis-methoxy TDM-KB52, TMM-KB51, GMM-SMP73 or 
AraMM-MOD16 (10µg /mouse) and ovalbumin (50µg /mouse) are shown in Figure 5 and 
Figure 6. Responses were compared with those obtained with a vehicle control (30% IFA + 
ovalbumin) or TDB w/o/w emulsions (30% IFA, TDB 10 µg/mouse and ovalbumin 50 
µg/mouse). As shown in Figure 5A, neither AraMM-MOD16 nor 30% IFA vehicle control 
induced any footpad swelling, while TDM-KB52, TMM-KB51 and GMM-SMP73 induced a 
footpad swelling of 1-2 mm over 7 days, comparable to the one observed for a w/o/w 
emulsion with TDB. Interestingly, GMM-SMP73 induced a significantly weaker footpad 
swelling than TDB.  Cells recruited to the site of injection were analysed by flow cytometry. 
The analysis of cells recruited to the footpad showed a high infiltration of granulocytes 
(Ly6C+ and Ly6G+) for TDB, natural TDM, TDM-KB52, TMM-KB51, GMM-SPM73 but 
not for AraMM-MOD16 (Fig.5B). qRT-PCR analysis confirmed that all the positive 
compounds (in terms of footpad swelling and granulocyte infiltration) induced also increased 
expression of pro-inflammatory cytokines (IL12p35, IL-1β, and TNF-α) and chemokine 
(CXCL1) as compared to vehicle control and AraMM-MOD16 (Fig.5C-F). No significant 
difference was observed between TDB, natural TDM, TDM-KB52, TMM-KB51 and GMM-
SMP73. Draining lymph node cell number increased twofold in animals injected with these 
five compounds, while the cell number was comparable in lymph nodes from animals injected 
with vehicle control or the AraMM-MOD16 group (Fig. 6A). Production of OVA-specific IL-
2, IFN-γ and IL-17A was measured in draining lymph node cell cultures stimulated in vitro 
with ovalbumin. Formulation with AraMM-MOD16 stimulated low levels of OVA-specific 
IL-2, IFN-γ and no IL-17A production, whereas formulation with TDM-KB52, TMM-KB51 
and GMM-SMP73 induced elevated levels of these cytokines, comparable to those achieved 
by TDB (Fig.6B-D).  
Our analysis of the in vitro inflammatory properties of the synthetic mycolate esters had 
shown that the class of mycolate bound to a given sugar exerted only a small influence on the 
magnitude of the inflammatory response (Figure 1). Nevertheless, there was a trend of the 
tested synthetic methoxy-TDM to induce more TNF-α than TDB or the alpha- and keto- 
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compounds. We therefore compared in vivo responses of w/o/w emulsions composed of cis-
alpha TDM-MH175 or TMM-MH176 with responses obtained with w/o/w emulsions 
composed of cis-methoxy TDM-KB52 or TMM-KB51. No differences between the cis-alpha 
and cis-methoxy mycolate esters could be observed in terms of footpad swelling and OVA-




The cell wall of mycobacteria is characterized by components that interact with different arms 
of the immune system in case of infection. Several of these components have been associated 
with virulence and capacity to modulate host immune responses. In this work, we were 
interested in analyzing the role of esters of mycolic acids using pure synthetic compounds. 
Mycolic acids are high molecular weight C-60 to C-90 2-alkyl-3-hydroxy fatty acids typical 
of mycobacteria. Different classes of mycolic acids are present in mycobacteria, mainly 
alpha-, keto- and methoxy- mycolic acids but also alkene and diene mycolic acids. In addition, 
mycolic acids can exist in different isomeric forms (e.g., cis- and trans-stereochemistry). In 
the mycobacterial cell wall, mycolic acids are present as free mycolic acids or esterified to 
different sugars (trehalose, glucose or arabinose). Trehalose dimycolate (TDM) or cord factor 
is probably the most abundant and best studied of the non- cell wall-bound mycolate esters 
and several studies have reported that changing the classes of MA in TDM influences its 
inflammatory properties. Indeed, TDM from the Mtb ΔcmaA2 mutant, lacking trans-
cyclopropanation of MAs, is hyperinflammatory for macrophages compared to TDM 
extracted from wild type Mtb [36]. Likewise, the cord factor isolated from Mtb ΔmmaA4, 
lacking oxygenated MA classes, induces in vitro more TNF-α and IL-12 in macrophages than 
TDM from wild type Mtb [4]. On the other hand, TDM isolated from Mtb ΔpcaA (an enzyme 
required for α-mycolate cyclopropanation) is hypoinflammatory in macrophages [5]. In this 
study we have analysed the inflammatory power of 17 pure synthetic TDMs along with 13 
TMMs, 5 GMMs and 3 AraMMs. Our results only partially confirm the data previously 
obtained using these mutant Mtb strains [4,5,36]. Indeed, the monoalkene TDM and 
particularly the dialkene TDM, lacking one and respectively two cyclopropanes,  show a 
lower inflammatory potential, confirming the findings of Rao et al [5]. However, we found 
that the class of mycolate (alpha- versus keto- versus methoxy-) and the cis- versus trans- 
conformation only poorly influences the intensity of the inflammatory responses induced by 
these compounds.  Cis-methoxy- mycolate esters seem to be more inflammatory compared to 
cis-alpha- and cis-keto- mycolate esters in vitro, but this observation was not confirmed in 
vivo. It is important to mention that the naturally isolated TDM preparations from Mtb 
mutants were composed of a complex mixture containing diverse mycolates in terms of class 
and chain length (C-60 to C-90), while the synthetic compounds tested in our study were of a 
particular class and generally restricted in chain length from C-74 to C-84. Synthetic 
compounds with chain lengths varying in a wider range between C-60 to C-90 need to be 
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tested to make definitive conclusions. Moreover, Ostrop and colleagues have shown that 
natural TDM induces a different profile of pro-inflammatory cytokines and chemokines 
compared to TDB in primary human APCs [37]. These results suggest a potential role of 
chain length or presence of chemical groups in the activation of primary human cells. To 
elucidate that, it would be of great interest to compare the inflammatory potential of the 
synthetic compounds of our study in primary human APCs.  
In addition, with this study we were able to demonstrate that besides TDMs and TMMs, 
GMMs and AraMMs are also inflammatory mycolate esters. Their ability to induce 
inflammatory responses is linked to their interaction with the C-type lectin receptor Mincle. 
Using BMDC of Mincle-/- mice and human reporter cells expressing murine Mincle, we show 
that  long-chain mycobacterial GMMs - similarly to corynebacterial GMMs – can indeed 
interact with Mincle [19]. These results are different from what previously reported by 
Ishikawa et al., who showed that GMM isolated by trehalose treatment of natural TDM does 
not interact with mouse Mincle receptor [18]. Possibly, this difference in results is linked to 
the use of products of enzymatic treatment as compared to the use of pure synthetic 
compounds in our study and in the study by van der Peet et al.. In addition, Matsunaga et al., 
reported that shortly after infection, mycobacteria have a down-regulated production of TDM 
and an up-regulated production of GMM [38]. This reciprocal regulation is caused by 
competitive substrate selection by antigen 85A. The results reported by Matsunaga et al., 
coupled to the results of Ishikawa et al., led to the hypothesis that up-regulation of GMM 
production is an escape mechanism of pathogenic mycobacteria to avoid recognition by the 
innate immune system [18,38]. Our results suggest that even if in vivo a down-regulation of 
TDM and an up-regulation of GMM occur, innate immune cells remain able to recognize 
GMM via Mincle.  
Regarding AraMMs, our results differ from what was described for natural AraMM purified 
from M. bovis BCG, for which a dependence on TLR-2 / Myd88 was reported [22]. However, 
in the Miyauchi paper, arabino-mycolate esters obtained by acid hydrolysis of BCG cell wall 
skeleton were used, which consist of a complex mixture of mono-arabinose monomycolates, 
tetra-arabinose tetra-mycolates, penta-arabinose tetra-mycolates and hexa-arabinose tetra-
mycolate. The relative proportion of these different compounds in the preparation was not 
quantified; we can therefore not exclude that mono-arabinose monomycolates signal via 
Mincle while the other arabinose mycolates would signal via TLR-2/MyD88. Noteworthy, to 
our knowledge, this is the first study demonstrating that the C-type receptor Mincle can 
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recognize pentose-based glycolipids, even if the intensity of the induced downstream signal 
was lower than the signal induced by trehalose- and glucose-based glycolipids.  
In addition, our study demonstrates that like TDMs, TMMs and GMMs also AraMMs induce 
the activation of the NLRP3 inflammasome. It should be noted that, even if the tested 
synthetic AraMMs were not as inflammatory as the synthetic TDMs, TMMs and GMMs in 
the in vitro and in vivo experiments performed, in an in vitro model involving an LPS priming 
of BMDCs, a level of IL-1β secretion was observed for all the tested AraMMs comparable to 
the levels observed for synthetic TDMs, TMMs and GMMs. This indicates that synthetic 
AraMMs have a potential comparable to the other synthetic mycolate esters to induce NLRP3 
inflammasome activation and hence pro-IL-1β processing. It is tempting to speculate that 
combining synthetic AraMM with a TLR-agonist could lead to the development of adjuvant 
formulations with Th1 and Th17 promoting potential. Indeed, the TLR agonist could trigger 
the production of pro-Th1 cytokines along with pro-IL-1β (similar to the LPS priming in our 
experimental set-up) and synthetic AraMM could lead to pro-IL-1β maturation by NLRP3 
activation resulting in induction of Th17 responses [24,39]. 
The in vivo analysis of the tested synthetic mycolate esters in IFA formulations with 
ovalbumin confirmed the inflammatory properties of synthetic TDMs, TMMs and GMMs as 
measured by footpad swelling following subcutaneous administration. No difference in terms 
of footpad swelling or OVA-specific T cell responses could be observed when comparing the 
cis-alpha TDM-MH175 or TMM-MH176 compounds to the cis-methoxy TDM-KB52 or 
TMM-KB51 compounds, indicating that also in vivo the class of mycolate does not influence 
the inflammatory power of mycolate esters. Interestingly, Huber and colleagues recently 
reported that trehalose monoesters with short acyl chains (C12, 14, 16, 18, 20) induce 
significantly lower Th1 and Th17 responses compared to trehalose diester analogues. These 
results demonstrated that the adjuvant property of simple fatty acids requires two acyl chains. 
In contrast to that study, we have observed comparable levels of Th1 and Th17 immune 
responses between TDM-KB52 and TMM-KB51 or between TDM-MH175 and TMM-
MH176 suggesting that with a longer acyl chain, TMMs can in vivo also trigger strong 
immune responses [40]. Differently from what was reported by Shenderov et al., purified 
peptidoglycan was not needed and formulation of these synthetic mycolate esters in IFA was 
sufficient in our hands to trigger antigen-specific Th17 responses along with Th1 responses 
[39]. Differences in formulation and read-outs could account for this discrepancy. Our results 
indicate that synthetic TDMs, TMMs and GMMs should be further evaluated as novel 
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adjuvants for subunit vaccines to be used against infectious diseases for which Th1 and Th17 
CD4+ T cell responses correlate with protection. However, it is known that natural TDM 
extracted from Mtb can be toxic in vivo [41]. Nevertheless, this toxicity is linked to the nature 
of the acyl chain bound to trehalose. Indeed, TDM from Rhodococcus sp.4306 with shorter 
chain length (C34-38) induces lower granulomatogenicity compared to TDM from Mtb [15]. 
In addition, using natural TDMs extracted from different mycobacteria species that varies in 
terms of the classes and proportions of mycolates present in their cell wall, Fujita and co-
workers showed that the classes of MA bound to trehalose can influence the toxicity of the 
molecule. Thus, toxicity of the synthetic compounds with an adjuvant potential described in 
this study should be assessed in vivo to down-select non-toxic compounds. 
GMMs from mycobacteria are also protective non-protein antigens recognized by CD1b 
restricted T cells. Hence, given this dual ability of GMMs to stimulate both innate and 
adaptive responses, it is tempting to speculate that administration of IFA formulations of 
synthetic GMMs with no additional adjuvant could stimulate protective immune responses. In 
future experiments it will be of interest to evaluate such formulations in animal models such 
as the guinea pigs or human group 1 CD1 transgenic mice [42]. In addition, as already 
analyzed for TMM [21] and in order to simplify the synthesis process, it would be interesting 
to determine the minimal carbon chain length necessary for the adjuvant potential of GMM 
and for its antigenic potential in TB vaccines. More importantly, this study raises an 
interesting possibility that GMM through Mincle and CD1b may contribute to both innate 
(induction of pro-inflammatory cytokines) and acquired (induction of Th1/Th17- CD1b 
restricted T cell responses) immunity against mycobacteria. This fact provides an interesting 
possibility in the TB vaccine field to target both classical and non-classical T cell responses 
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Legend to the figures: 
Figure 1. Synthetic trehalose mono- and dimycolate esters stimulate the in vitro 
production of TNF-α and IL-6 by Bone Marrow derived Dendritic Cells (BMDCs). 
A-B: BMDCs derived from C57BL/6 mice were stimulated for 24 h in triplicate cultures with 
increasing concentrations of plate-coated synthetic cis-methoxy TMM-KB51  (grey triangles), 
or  cis-methoxy TDM-KB52 (black triangles) or TDB (white diamonds). The supernatants 
were harvested from separate wells and the amount of pro-inflammatory cytokines (TNF-α 
and IL-6) was determined by sandwich ELISA. Results are expressed as mean pg/ml of 
cytokines ± SD of three independent experiments: TNF-α (A) or IL-6 (B).  
C: Separate BMDC cultures derived from C57BL/6 mice were stimulated for 24h in triplicate 
with 9 pairs of synthetic trehalose di- versus corresponding monomycolate esters at 0.1µM, 
with evaporated isopropanol as negative control and TDB or natural TDM at the same 
concentration as positive controls. The supernatants were harvested and the amount of TNF-α 
was determined by sandwich ELISA. Results are expressed as mean pg/mL of TNF-α ± SD 
and data of 4 representative experiments have been pooled. Statistical analysis of results 
obtained for the TDM/TMM pairs was performed by Mann-Whitney test: ns= not significant, 
* for p<0.05, ** for p<0.01 and *** for p<0.001.  
D: Separate BMDC cultures derived from C57BL/6 mice were stimulated for 24h in triplicate 
with single TDMs representative of the different classes and configurations (D) of mycolates 
present in mycobacteria at 1µM, with evaporated isopropanol as negative control and TDB or 
natural TDM at the same concentration as positive controls. The supernatants were harvested 
and the amount of TNF-α was determined by sandwich ELISA. Results are expressed as mean 
pg/mL of TNF-α ± SD and data of 3 representative experiments have been pooled. Statistical 
analysis of the results of the different groups was performed by Mann-Whitney test: ns= not 
significant, * for p<0.05, ** for p<0.01 and *** for p<0.001. Isopropanol (stars), TDM 
natural mix (crossed circles), TDB (white diamonds), cis-alpha TDM-MH175 (black circles), 
trans-alpha TDM-MMS139 (white circles), cis-keto TDM-AD132 (black squares), trans-keto 
TDM-RT82F2 (white squares), cis-methoxy TDM-KB52 (black triangles) and trans-methoxy 
TDM-RT126 (white triangles).   
 
Figure 2. Synthetic glucose monomycolates and arabinose monomycolates activate 
BMDCs. 
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A-D- BMDC cultures from C57BL/6 mice were stimulated for 24 h in triplicate with 
escalating concentrations of  plate-coated synthetic mycolate esters composed of a same cis-
methoxy mycolate bound twice to trehalose (TDM-KB52) or once to trehalose (TMM-KB51) 
or glucose (GMM-SMP73) or arabinose (AraMM-MOD16) or controls (natural TDM mix, 
TDB or evaporated isopropanol (ISO)). The supernatants were harvested and the amounts of 
pro-inflammatory cytokines (IL-6 (A), IL-1β (B), TNF-α (C) and IL-12p40 (D)) were 
determined by ELISA. Results are expressed as mean pg/ml of cytokines ± SD  (n=four 
independent experiments). Statistical analysis on results obtained for synthetic compounds 
and natural TDM mix compared to TDB was performed by Mann Whitney test: ns= not 
significant, * for p<0.05, ** for p<0.01 and *** for p<0.001  
E- Up-regulation of co-stimulatory molecules (CD86 and CD80) and MHC class II was 
evaluated by flow cytometric analysis after 48 h of stimulation with 10µg/mL of synthetic 
mycolate esters composed of a same cis-methoxy mycolate bound twice to trehalose (TDM-
KB52) or once to trehalose (TMM-KB51) or glucose (GMM-SMP73) or arabinose (AraMM-
MOD16) and controls (unstimulated, LPS (100 ng/mL ) or TDB (10µg/mL)). Results are 
means ± SD and representative of at least three independent experiments. Statistical analysis 
on results obtained for synthetic compounds, TDB or LPS compared to unstimulated cells was 
performed by Mann Whitney test: ns= not significant, * for p<0.05.  
F-BMDCs were treated for 30 minutes with 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA) and stimulated for 4h with 10µg/mL of synthetic mycolate esters composed of a 
same cis-methoxy mycolate bound twice to trehalose (TDM-KB52) or once to trehalose 
(TMM-KB51) or glucose (GMM-SMP73) or arabinose (AraMM-MOD16) and controls 
(unstimulated, PMA (100ng/mL or TDB (10µg/mL)). The production of ROS by the tested 
compound (black line) was measured by flow cytometry and compared to unstimulated cells 
(grey shade).  
 
Figure 3. Synthetic GMM and AraMM activate BMDCs by Mincle dependent 
mechanisms. 
A, B and C- BMDCs from C57BL/6 WT, MyD88-/-, FcRγ-/- , Mincle-/- and MALT1-/- mice 
were stimulated in triplicate with 10µg/mL of different synthetic mycolate esters, TDB, 
natural TDM mix or negative control (evaporated isopropanol) for 24 h. The supernatants 
were analysed for their content in pro-inflammatory cytokines (TNF-α) by ELISA. Results are 
expressed as mean pg/mL of TNF-α ± SD and are representative of at least 4 independent 
experiments. 
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 D- HEK293 reporter cell expressing murine Mincle were used to evaluate the binding to 
Mincle receptor. SEAP release after NF-κB activation was evaluated by colorimetric assay 
using Quantie-blue substrate and by measuring the OD at 655 nm. Isopropanol (stars), TDM 
natural mix (crossed circles), TDB (white diamonds), cis-methoxy TDM-KB52 (black 
triangles), cis-methoxy TMM-KB51 (grey triangles), cis-methoxy GMM-SMP73 (white 
triangles) and cis-methoxy AraMM-MOD16 (white and black triangles). 
Figure 4. Synthetic glucose and arabinose mycolate esters activate the NLRP3 
inflammasome  
A: BMDCs prepared from C57BL/6 mice were primed for 3 h with 1µg/mL of ultrapure LPS 
and stimulated next for 5 h with 10µg/mL of synthetic mycolate esters, with evaporated 
isopropanol as negative control and TDB or natural TDM mix at the same concentration as 
positive controls. The supernatants were harvested and the amount of IL-1β in the 
supernatants was determined by ELISA  
B: The secretion of active caspase-1-p20 was detected by Western blot in the supernatant after 
methanol-chloroform precipitation  
C- Quantification of Caspase-1 p20 in the supernatant. Relative intensity of Caspase-1 p 20 
was determined relative to a non-specific (NS) band. NS band was used as loading control in 
the supernatant.  
D-E BMDCs from C57BL/6 mice were primed with 1µg/mL of ultrapure LPS for 2 h, 
incubated with 10 µM of Z-VAD-FMK (grey) or control medium (black) for 1 h and 
stimulated with 10µg/mL of synthetic mycolate esters and controls for 5h. Secretion of IL-1β 
(D) and TNF-α (E) was determined by ELISA in the supernatants  
F-G BMDCs were prepared from WT (black), NLRP3-/- (grey) and Caspase1/11-/- (white) 
C57BL/6 mice and primed for 3 h with 1µg/mL of ultrapure LPS before stimulation for 5 h 
with 10µg/mL of synthetic mycolate esters and controls. The amount of IL-1β (F) and TNF-α 
(G) in the supernatants was determined by ELISA. Results represent mean ± SD of triplicate 
cultures and are representative of at least two independent experiments.  
 
Figure 5. In vivo inflammatory properties of synthetic mycolate esters. 
C57BL/6 mice were injected s.c in the two hind footpads with w/o/w emulsions composed of 
30% Incomplete Freund’s Adjuvant, 10µg/mouse of specified synthetic mycolate esters and 
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50 µg/mouse of ovalbumin. In the emulsion of the vehicle control group no glycolipid was 
present, in the TDB control group 10 µg/mouse of TDB replaced the synthetic glycolipids. 
A: Mean footpad size (mm) of five mice tested individually was measured with a caliper on 
the day of injection and 1, 3 and 7 days after injection.  
B: Percentage of granulocytes (Ly6G+ and Ly6C+) was determined in cells isolated from 
footpad by flow cytometry 7 days post administration. 
C-F: The relative expression of cytokines and chemokine were determined by qRT-PCR in 
the footpad cells. Fold change was determined in comparison to vehicle.  
Footpad swelling and percentage of granulocytes induced by synthetic mycolate esters were 
statistically analysed in comparison to TDB using Mann-Whitney test: ns= not significant, * 
for p<0.05, ** for p<0.01 and *** for p<0.001.  
 
Figure 6. In vivo adjuvant potential of synthetic mycolate esters in an experimental OVA 
model. 
A: C57BL/6 mice were injected s.c in the two hind footpads with w/o/w emulsions composed 
of 30% Incomplete Freund’s Adjuvant, 10µg/mouse of specified synthetic mycolate esters 
and 50 µg/mouse of ovalbumin. In the emulsion of the vehicle control group no glycolipid 
was present, in the TDB control group 10 µg/mouse of TDB replaced the synthetic 
glycolipids. Mice were sacrificed 7 day post immunisation and cells from pooled popliteal 
and inguinal lymph nodes were collected, counted (A) and stimulated with culture medium 
(RPMI) or with 5µg/ml of ovalbumin (OVA) for 24h or 72h. Supernatants were harvested and 
the concentration of IL-2 (B) and IFN-γ/IL-17A (C and D) was determined by ELISA.   
Results are means ± SD of five mice tested individually and representative of at least four 
independent experiments. ns= not significant, *, **, ***= statistically significant, as 
determined by Mann-Whitney test, p<0.05, p<0.01 or p<0.001. 
 
Table 1. Structures and code names of the tested synthetic mycolate esters. 
 
 
Table S1. All the tested synthetic trehalose mycolate esters induce the production of 
TNF-alpha and IL-6 by Bone Marrow derived Dendritic Cells (BMDCs) 
BMDCs derived from C57BL/6 mice were stimulated for 24 h in triplicate with 10 µg/mL of 
plate-coated synthetic trehalose mycolate esters or controls (TDB, TDM natural mix or 
evaporated isopropanol (ISO)). The supernatants were harvested individually and the amount 
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of pro-inflammatory TNF-alpha and IL-6 was determined by sandwich ELISA. Results are 
expressed as mean pg/mL of cytokines ± SD of triplicate cultures and representative of at 
least three independent experiments. 
 
Figure S1: Synthetic trehalose dimycolate esters of different classes and configuration 
stimulate the in vitro production of TNF-α by Bone Marrow derived Dendritic Cells 
(BMDCs). 
BMDCs cultures derived from C57BL/6 mice were stimulated for 24h in triplicate with single 
TDMs representative of the different classes and configurations (cis vs trans) of mycolates 
present in mycobacteria at escalating doses of 0.001µM (black and white bars), 0.01µM 
(white bars), 0.1 µM (grey bars) or 1µM (black bars), with evaporated isopropanol as 
negative control and TDB and a natural mix of TDM at the same concentrations as positive 
controls. The supernatants were harvested and the amount of TNF-α was determined by 
sandwich ELISA. Results are expressed as mean pg/mL of TNF-α ± SD and data of 4 
representative experiments have been pooled. 
 
Figure S2. Synthetic glucose monomycolates and arabinose monomycolates activate 
BMDCs. 
BMDCs from C57BL/6 mice were stimulated for 24 h in triplicate with 1µM of plate-coated 
synthetic GMMs, AraMMs or controls (TDB or evaporated isopropanol (ISO)) Supernatants 
were harvested and the amount of TNF-α was determined by ELISA. Results are expressed as 
mean pg/mL of TNF-α ± SD and data of 3 representative experiments have been pooled. 
 
Figure S3. TDMs activate BMDCs by Mincle dependent mechanisms. 
BMDCs from C57BL/6 WT, FcRγ-/- , and Mincle-/- mice were stimulated in triplicate with 10 
µg/mL of different synthetic trehalose dimycolates, TDB, natural TDM mix or negative 
control (evaporated isopropanol) for 24 h. The supernatants were analyzed for their content in 
pro-inflammatory cytokines (TNF-α) by ELISA. Results are expressed as mean pg/mL of 
TNF-α ± SD of triplicate cultures and data are representative of at least 4 independent 
experiments.  
 
Figure S4. Mechanisms involved in the activation of inflammasome by GMM and 
AraMM  
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A-D: BMDCs from C57BL/6 mice were primed with 1µg/mL of ultrapure LPS for 2 h, 
pretreated 1 h or not (black bars) with 10 µM of Ebselen (A-grey bars), with 50 µM of 
glibenclamide (B-grey bars) or 50mM of KCl (B-white bars) or with 10µM of CA-074 (C-
grey bars) or 1 µM of cytochalasin D (D-grey bars) and stimulated 5 h with 10µg/mL of 
synthetic mycolate esters and controls. The level of IL-1β was determined in the supernatant 
by ELISA. Results are means ± SD of triplicate cultures and representative of at least three 
independent experiments. 
 
Figure S5. In vivo inflammatory properties of synthetic mycolate esters and adjuvant 
potential.  
C57BL/6 mice were injected s.c in the hind footpads with w/o/w emulsions composed of 30% 
Incomplete Freund’s Adjuvant, 10µg/mouse of specified synthetic mycolate esters and 50 
µg/mouse of ovalbumin. In the emulsion of the vehicle control group no glycolipid was 
present, in the TDB control group 10 µg/mouse of TDB replaced synthetic glycolipid in the 
emulsion. 
A: footpad swelling measured with a caliper on the day of injection and 1, 3 and 7 days after 
injection. B: cell counts in the lymph nodes draining the injection site 7 days post 
administration 
C and D: IFN-γ and IL-17A concentrations measured by ELISA on 72h supernatants of 
pooled popliteal and inguinal lymph node cells stimulated with culture medium (RPMI) or 






Structure of mycolic acid 
TDM TMM GMM AraMM 
 
 
    
























































 [27] ST165  [27]   


































[31] RT86 [31]    trans-keto CH3(CH2)17 (CH2)18O (CH2)16 OH O(CH2)23CH3OH   SMP75  [26] MOD23  [25] 




















 [26]  
34  
Table 1. Structure, class, code names and reference to synthesis of the tested synthetic mycolate ester 
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